Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhavsai Gajjar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
F1000Research|March 20, 2018
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?Joke Terryn, Tine Tricot, Madhavsai Gajjar, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2008
The p53 mRNA-Mdm2 interactionNadia Naski, Madhavsai Gajjar, Karima Bourougaa, et al.
Cancer Cell|January 24, 2012
The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damageMadhavsai Gajjar, Marco M Candeias, Laurence Malbert-Colas, et al.
Translational Psychiatry|August 23, 2019
Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytesAbdulsamie M Patel, Keimpe Wierda, Lieven Thorrez, et al.
BMC Cancer|January 24, 2016
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell linesHaatisha Jandu, Kristina Aluzaite, Louise Fogh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 22, 2022
CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicityWenting Guo, Haibo Wang, Arun Kumar Tharkeshwar, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
F1000Research|March 20, 2018
Recent advances in lineage differentiation from stem cells: hurdles and opportunities?Joke Terryn, Tine Tricot, Madhavsai Gajjar, et al.
Cell Cycle (Georgetown, Tex.)|December 25, 2008
The p53 mRNA-Mdm2 interactionNadia Naski, Madhavsai Gajjar, Karima Bourougaa, et al.
Cancer Cell|January 24, 2012
The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damageMadhavsai Gajjar, Marco M Candeias, Laurence Malbert-Colas, et al.
Translational Psychiatry|August 23, 2019
Dystrophin deficiency leads to dysfunctional glutamate clearance in iPSC derived astrocytesAbdulsamie M Patel, Keimpe Wierda, Lieven Thorrez, et al.
BMC Cancer|January 24, 2016
Molecular characterization of irinotecan (SN-38) resistant human breast cancer cell linesHaatisha Jandu, Kristina Aluzaite, Louise Fogh, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 22, 2022
CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicityWenting Guo, Haibo Wang, Arun Kumar Tharkeshwar, et al.
Pageof 1